World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
43851
World Ranking
7883
National Ranking
4107

Brenda M. Sandmaier publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Brenda M. Sandmaier sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 606 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Brenda M. Sandmaier D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Brenda M. Sandmaier sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Brenda M. Sandmaier is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on hematology, with significant contributions in hematopoietic stem cell transplantation, acute myeloid leukemia research, and acute lymphoblastic leukemia research.

The scientist's work spans multiple fields within medicine, including public health, environmental and occupational health, oncology, genetics, and radiology, nuclear medicine, and imaging. Within these domains, key topics of their research include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Radiopharmaceutical Chemistry and Applications
  • Neutropenia and Cancer Infections
  • Immune Cell Function and Interaction

Brenda M. Sandmaier has collaborated frequently with several researchers, including:

  • Roland B. Walter
  • Frederick R. Appelbaum
  • Megan Othus
  • Johnnie J. Orozco
  • Partow Kebriaei

The scientist has published extensively in various academic journals, with frequent venues including:

  • Blood
  • Transplantation and Cellular Therapy
  • Bone Marrow Transplantation
  • Leukemia
  • Blood Advances

Notable recent papers by Brenda M. Sandmaier include:

  • "Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts" (2020, Annals of Internal Medicine)
  • "Acute graft-versus-host disease" (2023, Nature Reviews Disease Primers)
  • "Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML" (2022, Blood)
  • "Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia" (2021, Blood)
  • "Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR" (2021, Leukemia)

Best Publications

  • Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

    Mohamed L. Sorror;Michael B. Maris;Michael B. Maris;Rainer Storb;Rainer Storb;Frederic Baron

  • HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Heather J. Symons;Allen R. Chen

  • Defining the intensity of conditioning regimens: working definitions.

    Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt

  • Reduced mortality after allogeneic hematopoietic-cell transplantation.

    Ted A. Gooley;Jason W. Chien;Jason W. Chien;Steven A. Pergam;Steven A. Pergam;Sangeeta Hingorani;Sangeeta Hingorani

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.

    Sergio Giralt;Karen Ballen;Douglas Rizzo;Andreas Bacigalupo

  • Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

    Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf

  • Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

    Marco Mielcarek;Paul J. Martin;Wendy Leisenring;Mary E. D. Flowers

  • Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.

    Boglarka Gyurkocza;Boglarka Gyurkocza;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.

    Takahiro Fukuda;Michael Boeckh;Michael Boeckh;Rachel A. Carter;Rachel A. Carter;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

    Mohamed L. Sorror;Brenda M. Sandmaier;Barry E. Storer;Michael B. Maris

  • Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

    David G. Maloney;Arthur J. Molina;Firoozeh Sahebi;Keith E. Stockerl-Goldstein

  • Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.

    Mohamed L. Sorror;Michael B. Maris;Barry Storer;Brenda M. Sandmaier

  • Cord-Blood Transplantation in Patients with Minimal Residual Disease

    Filippo Milano;Ted Gooley;Brent Wood;Ann Woolfrey

  • Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

    Mohamed L. Sorror;Sergio Giralt;Brenda M. Sandmaier;Brenda M. Sandmaier;Marcos J.G. de Lima

  • Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

    Frédéric Baron;Michael B. Maris;Brenda M. Sandmaier;Barry E. Storer

  • Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation

    Mohamed L. Sorror;Rainer F. Storb;Brenda M. Sandmaier;Richard T. Maziarz

  • HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

    Michael B. Maris;Dietger Niederwieser;Brenda M. Sandmaier;Barry Storer

  • Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.

    Razvan Diaconescu;Christopher R. Flowers;Barry Storer;Mohamed L. Sorror

  • Hematopoietic cell transplantation (HCT)-specific-comorbidity index: A new tool for risk assessment before allogeneic HCT

    M.L. Sorror;M.B. Maris;M.B. Maris;R.F. Storb;R.F. Storb;F. Baron

Frequent Co-Authors

Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Ted Gooley
Ted Gooley Fred Hutchinson Cancer Research Center
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Michael A. Pulsipher
Michael A. Pulsipher University of Utah
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
Oliver W. Press
Oliver W. Press University of Washington
Mary E.D. Flowers
Mary E.D. Flowers Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering studying Medicine in the USA, there are a variety of alternative online degrees and career pathways worth exploring. Many students interested in healthcare choose to pursue a health administration degree online, which opens doors to leadership roles in hospitals, clinics, and other medical organizations.

For those seeking advanced career growth, affordable cheap mha programs can be a strategic option. These master's degrees offer specialized training in managing healthcare systems, making graduates competitive for higher-level managerial positions.

Medical professionals aiming for the highest credentials may consider cheap dnp online programs. A Doctor of Nursing Practice (DNP) degree leads to roles in advanced nursing practice, health policy, and clinical leadership.

Additionally, those interested in pharmaceuticals can find reputable online pharmacy schools. Earning a PharmD online equips graduates for careers ranging from clinical pharmacists to research and academia.

Regardless of your interests, online healthcare degrees offer flexibility and affordability, making it easier to tailor your education to your career goals.

Best Scientists Citing Brenda M. Sandmaier

Trending Scientists